We herein examined the immunohistological expression of p16 INK4a in lichen planus (LP, n = 8), graft-versus-host disease (GVHD, n = 5), drug eruption (n = 7), eczema (n = 5), psoriasis (n = 5) and normal skin (n = 5) using formalin-fixed and paraffin-embedded tissues. Sections were deparaffinized with xylene for 10 min and rehydrated through a graded series of ethanol. Antigen retrieval was performed using Heat Processor Solution pH6 (Nichirei Biosciences, Tokyo, Japan) at 100°C for 40 min, and endogenous peroxidase was blocked by incubating the sections with 3% H 2 O 2 (Nichirei Biosciences). The sections were then incubated with monoclonal antibody against p16 INK4a (E6H4, CINtec; Roche MTM Laboratories,
Inflammation induces various cellular responses including senescence. The protein 16
INK4a (p16 INK4a ) downregulates the kinase activity of cyclin-dependent kinases 4 and 6 and inhibits cell cycle progression. 1 Moreover, p16 INK4a is strongly associated with the cellular senescence process and its expression is upregulated by a diverse array of aging stimuli such as inflammatory cytokines. 1,2 However, only a few studies have examined the p16 INK4a expression in inflammatory skin diseases.
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We herein examined the immunohistological expression of p16 INK4a in lichen planus (LP, n = 8), graft-versus-host disease (GVHD, n = 5), drug eruption (n = 7), eczema (n = 5), psoriasis (n = 5) and normal skin (n = 5) using formalin-fixed and paraffin-embedded tissues. Sections were deparaffinized with xylene for 10 min and rehydrated through a graded series of ethanol. Focal but intense immunopositivity was evident in oral LP, 4 but it has never been investigated in cutaneous LP. The present study is the first to demonstrate that cutaneous LP exhibited p16 INK4a expression more frequently and intensely than GVHD, drug eruption, eczema and psoriasis. Inflammatory cytokines such as interferon (IFN)-c, tumor necrosis factor-a and transforming growth factor-b are active inducers of p16
INK4a expression in human keratinocytes.
